PubMed

Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series.

Lowes MA, Chamian F, Abello MV, Leonardi C, Dummer W, Papp K, Krueger JG.

BMC Dermatol. 2007 Feb 26;7:2.PMID: 17324275 [PubMed - indexed for MEDLINE]Related articlesFree article

Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness.

Guttman-Yassky E, Vugmeyster Y, Lowes MA, Chamian F, Kikuchi T, Kagen M, Gilleaudeau P, Lee E, Hunte B, Howell K, Dummer W, Bodary SC, Krueger JG.

J Invest Dermatol. 2008 May;128(5):1182-91. Epub 2008 Jan 31.PMID: 18239614 [PubMed - indexed for MEDLINE]Related articlesFree article

Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).

Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R, Novitskaya I, Carbonaro H, Cardinale I, Kikuchi T, Gilleaudeau P, Sullivan-Whalen M, Wittkowski KM, Papp K, Garovoy M, Dummer W, Steinman RM, Krueger JG.

Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):19057-62.PMID: 16380428 [PubMed - indexed for MEDLINE]Related articlesFree article

Efalizumab-associated papular psoriasis.

Hassan AS, Simon D, Simon HU, Braathen LR, Yawalkar N.

Arch Dermatol. 2007 Jul;143(7):900-6.PMID: 17638735 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis.

Ng CM, Joshi A, Dedrick RL, Garovoy MR, Bauer RJ.

Pharm Res. 2005 Jul;22(7):1088-100. Epub 2005 Jul 22.PMID: 16028009 [PubMed - indexed for MEDLINE]Related articles

Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin.

Vugmeyster Y, Kikuchi T, Lowes MA, Chamian F, Kagen M, Gilleaudeau P, Lee E, Howell K, Bodary S, Dummer W, Krueger JG.

Clin Immunol. 2004 Oct;113(1):38-46.PMID: 15380528 [PubMed - indexed for MEDLINE]Related articles

The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by Multi-Epitope Ligand Cartography robot technology. Introduction of a novel biological drug-binding biochip assay.

Bonnekoh B, Böckelmann R, Pommer AJ, Malykh Y, Philipsen L, Gollnick H.

Skin Pharmacol Physiol. 2007;20(2):96-111. Epub 2006 Dec 13.PMID: 17167274 [PubMed - indexed for MEDLINE]Related articles

Treatment of hand and foot psoriasis with emphasis on efalizumab.

Kircik L.

Skin Therapy Lett. 2007 Nov;12(9):4-7. Review.PMID: 18087658 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of therapeutic integrin (CD11a) blockade with efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study.

Krueger JG, Ochs HD, Patel P, Gilkerson E, Guttman-Yassky E, Dummer W.

J Invest Dermatol. 2008 Nov;128(11):2615-24. Epub 2008 May 22.PMID: 18496564 [PubMed - indexed for MEDLINE]Related articlesFree article

The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital.

Antoniou C, Stefanaki I, Stratigos A, Avgerinou G, Stavropoulos P, Potouridou I, Polidorou D, Moustou AE, Kosmadaki M, Katsambas AD.

Br J Dermatol. 2007 Apr;156 Suppl 2:12-6.PMID: 17371318 [PubMed - indexed for MEDLINE]Related articles

Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.

de Groot M, de Rie MA, Bos JD.

Br J Dermatol. 2005 Oct;153(4):843-4. No abstract available. PMID: 16181475 [PubMed - indexed for MEDLINE]Related articles

Anti-adhesion antibodies efalizumab, a humanized anti-CD11a monoclonal antibody.

Dedrick RL, Walicke P, Garovoy M.

Transpl Immunol. 2002 May;9(2-4):181-6. Review.PMID: 12180828 [PubMed - indexed for MEDLINE]Related articles

Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment.

Bonnekoh B, Pommer AJ, Böckelmann R, Hofmeister H, Philipsen L, Gollnick H.

Skin Pharmacol Physiol. 2007;20(5):237-52. Epub 2007 Jun 22.PMID: 17587888 [PubMed - indexed for MEDLINE]Related articles

[Efalizumab]

Descamps V.

Ann Dermatol Venereol. 2006 Aug-Sep;133(8-9 Pt 1):666-78. Review. French. PMID: 17053736 [PubMed - indexed for MEDLINE]Related articles

Efalizumab.

Chacko M, Weinberg JM.

Dermatol Ther. 2007 Jul-Aug;20(4):265-9. Review.PMID: 17970891 [PubMed - indexed for MEDLINE]Related articles

Exacerbation of psoriasis under efalizumab therapy.

Rallis E, Verros C, Karanikola E, Valaskatzi A, Papaconstantis M.

J Cutan Med Surg. 2009 Mar-Apr;13(2):106-9.PMID: 19298780 [PubMed - indexed for MEDLINE]Related articles

In vitro internalization, intracellular transport, and clearance of an anti-CD11a antibody (Raptiva) by human T-cells.

Coffey GP, Stefanich E, Palmieri S, Eckert R, Padilla-Eagar J, Fielder PJ, Pippig S.

J Pharmacol Exp Ther. 2004 Sep;310(3):896-904. Epub 2004 Jun 9.PMID: 15190122 [PubMed - indexed for MEDLINE]Related articlesFree article

Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series.

Lowes MA, Turton JA, Krueger JG, Barnetson RS.

BMC Dermatol. 2005 Aug 18;5:9.PMID: 16109173 [PubMed - indexed for MEDLINE]Related articlesFree article

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.

Cather JC, Cather JC, Menter A.

Expert Opin Biol Ther. 2003 Apr;3(2):361-70. Review.PMID: 12662148 [PubMed - indexed for MEDLINE]Related articles

Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis.

Viguier M, Richette P, Aubin F, Beylot-Barry M, Lahfa M, Bedane C, Delesalle F, Richard-Lallemand MA, Delaporte E, Dubertret L, Bardin T, Bachelez H.

Arthritis Rheum. 2008 Jun;58(6):1796-802.PMID: 18512820 [PubMed - indexed for MEDLINE]Related articlesFree article